Healthcare provider profile · identity verified

Neil Bowman

Nurse Practitioner · CASSOPOLIS, MI · NPI 1437507464

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	335	82
Atorvastatin Calcium	Atorvastatin Calcium	319	79
Amlodipine Besylate	Amlodipine Besylate	221	65
Metoprolol Tartrate	Metoprolol Tartrate	184	43
Omeprazole	Omeprazole	168	29
Metformin Hcl	Metformin Hcl	144	32
Allopurinol	Allopurinol	136	24
Hydrochlorothiazide	Hydrochlorothiazide	126	35
Glipizide	Glipizide	111	24
Levothyroxine Sodium	Levothyroxine Sodium	111	22
Ibuprofen	Ibuprofen	109	30
Tizanidine Hcl	Tizanidine Hcl	109	22
Trazodone Hcl	Trazodone Hcl	107	22
Simvastatin	Simvastatin	103	22
Gabapentin	Gabapentin	92	15
Pravastatin Sodium	Pravastatin Sodium	92	25
Jardiance	Empagliflozin	86	16
Furosemide	Furosemide	84	22
Albuterol Sulfate Hfa	Albuterol Sulfate	83	23
Tamsulosin Hcl	Tamsulosin Hcl	80	25
Meloxicam	Meloxicam	77	17
Pantoprazole Sodium	Pantoprazole Sodium	74	23
Prednisone	Prednisone	64	49
Famotidine	Famotidine	63	14
Ropinirole Hcl	Ropinirole Hcl	62	suppressed
Losartan Potassium	Losartan Potassium	59	20
Hydralazine Hcl	Hydralazine Hcl	58	suppressed
Citalopram Hbr	Citalopram Hydrobromide	56	suppressed
Clonidine Hcl	Clonidine Hcl	56	11
Carvedilol	Carvedilol	50	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	13
Duloxetine Hcl	Duloxetine Hcl	48	12
Clopidogrel	Clopidogrel Bisulfate	46	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	16
Pregabalin	Pregabalin	46	suppressed
Potassium Chloride	Potassium Chloride	45	suppressed
Spironolactone	Spironolactone	44	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	41	14
Topiramate	Topiramate	41	suppressed
Metformin Hcl Er	Metformin Hcl	39	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Atenolol	Atenolol	37	12
Fluticasone Propionate	Fluticasone Propionate	37	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	30
Cephalexin	Cephalexin	36	24
Ezetimibe	Ezetimibe	36	11
Buspirone Hcl	Buspirone Hcl	35	11
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Montelukast Sodium	Montelukast Sodium	34	suppressed
Warfarin Sodium	Warfarin Sodium	34	suppressed
Metoprolol Succinate	Metoprolol Succinate	33	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	33	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	33	suppressed
Eliquis	Apixaban	30	suppressed
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	13
Ventolin Hfa	Albuterol Sulfate	29	13
Donepezil Hcl	Donepezil Hcl	27	suppressed
Gemfibrozil	Gemfibrozil	27	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	suppressed
Clonazepam	Clonazepam	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	19
Meclizine Hcl	Meclizine Hcl	23	11
Naproxen	Naproxen	22	suppressed
Terbinafine Hcl	Terbinafine Hcl	21	suppressed
Torsemide	Torsemide	21	suppressed
Fluconazole	Fluconazole	20	13
Hydroxyzine Pamoate	Hydroxyzine Pamoate	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	19	suppressed
Glimepiride	Glimepiride	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Finasteride	Finasteride	17	suppressed
Nystatin	Nystatin	17	suppressed
Trulicity	Dulaglutide	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Benztropine Mesylate	Benztropine Mesylate	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Baclofen	Baclofen	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Colchicine	Colchicine	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	11
Humulin R U-500	Insulin Regular, Human	12	suppressed
Ibu	Ibuprofen	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	12	suppressed
Nurtec Odt	Rimegepant Sulfate	12	suppressed
Ozempic	Semaglutide	12	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Tramadol Hcl	Tramadol Hcl	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error